Age-Adjusted D-Dimer Testing Improves Ability to Rule Out PE

Share this content:
Age-Adjusted D-Dimer Testing Improves Ability to Rule Out PE
Age-Adjusted D-Dimer Testing Improves Ability to Rule Out PE

WEDNESDAY, May 18, 2016 (HealthDay News) -- Compared with fixed D-dimer testing, age-adjusted D-dimer testing is associated with an increase in the proportion of patients with suspected pulmonary embolism (PE) in whom imaging can be withheld, according to a review published online May 17 in the Annals of Internal Medicine.

Nick van Es, M.D., from the Academic Medical Center in Amsterdam, and colleagues used data from six prospective studies to examine and compare the efficiency and safety of the Wells rule with fixed or age-adjusted D-dimer testing. Data were included for 7,268 inpatients and patients with cancer, chronic obstructive pulmonary disease, previous venous thromboembolism, delayed presentation, and age 75 years or older.

The researchers estimated the proportion of patients in whom imaging could be withheld based on a "PE-unlikely" Wells score and a negative D-dimer test result (efficiency) using fixed and age-adjusted D-dimer thresholds. They also estimated the three-month incidence of symptomatic venous thromboembolism (failure rate). When the age-adjusted D-dimer threshold was applied (instead of fixed), efficiency increased from 28 to 33 percent. Elderly patients had a more prominent increase (12 percent), while inpatients had a less prominent increase (2.6 percent). In all examined subgroups, the failure rate of age-adjusted D-dimer testing was less than 3 percent.

"This strategy seems safe across different high-risk subgroups, but its efficiency varies," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Keytruda for All Cancers With Genetic Biomarker

FDA Approves Keytruda for All Cancers With Genetic ...

First medication sanctioned for any cancer, regardless of origin

Regular Chocolate Consumption May Lower Risk of A-Fib

Regular Chocolate Consumption May Lower Risk of A-Fib

13-year study finds lower odds for atrial fibrillation in people eating moderate amounts

Doctors Urged to Check Patient Drug History Before Opioid Rx

Doctors Urged to Check Patient Drug History Before ...

Opioid abuse down when physicians are legally obligated to check patient's drug history

is free, fast, and customized just for you!

Already a member?

Sign In Now »